Extension of the Psychometric Validation Study ORCHESTRA in Patients With PAH
Status:
Completed
Trial end date:
2018-09-19
Target enrollment:
Participant gender:
Summary
Prospective, multi-center, open-label, single-arm, Phase 3b extension study of macitentan in
patients with PAH.
To assess the long-term safety of macitentan in patients with pulmonary arterial hypertension
(PAH) beyond treatment in the AC-055-310 study.